Alaunos Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $2 | $4 | $0 |
Gross Profit | 2 | 4 | 4 | |
EBITDA | -1,039 | -1,073 | -742 | -1,127 |
EBIT | -741 | -741 | -1,150 | |
Net Income | -1,051 | -1,073 | -742 | -1,127 |
Net Change In Cash | 0 | 2 | 4 | 0 |
Free Cash Flow | 8,474 | -772 | -592 | 28,897 |
Cash | 2,879 | 319 | 1,091 | 1,683 |
Basic Shares | 1,676 | 1,601 | 1,601 | 1,601 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10 | $5 | $2,922 | $398 |
Gross Profit | 10 | -4,798 | 163 | -342 |
EBITDA | -4,677 | -30,904 | -31,817 | -74,972 |
EBIT | -4,679 | -33,219 | -34,576 | -77,569 |
Net Income | -4,679 | -35,140 | -37,597 | -76,894 |
Net Change In Cash | 10 | 5 | 2,922 | 398 |
Cost of Revenue | -23,058 | |||
Free Cash Flow | -4,971 | -30,339 | -29,448 | -64,791 |
Cash | 1,091 | 6,062 | 39,058 | 76,054 |
Basic Shares | 1,601 | 1,599 | 1,447 | 1,429 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.63 |
2025-03-31 | -$0.67 |
2024-12-31 | -$0.46 |
2024-09-30 | -$0.70 |
